Edwards Lifesciences Corp (NYSE: EW) is -7.43% lower on its value in year-to-date trading and has touched a low of $58.93 and a high of $96.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EW stock was last observed hovering at around $70.33 in the last trading session, with the day’s loss setting it -1.8%.
Currently trading at $68.53, the stock is -5.73% and -5.19% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.77 million and changing -2.56% at the moment leaves the stock -7.14% off its SMA200. EW registered -22.42% loss for a year compared to 6-month gain of 3.80%.
The stock witnessed a -3.47% loss in the last 1 month and extending the period to 3 months gives it a -7.64%, and is -4.01% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.78% over the week and 2.23% over the month.
Edwards Lifesciences Corp (EW) has around 15800 employees, a market worth around $40.29B and $5.72B in sales. Current P/E ratio is 28.76 and Fwd P/E is 24.92. Profit margin for the company is 24.95%. Distance from 52-week low is 16.29% and -28.70% from its 52-week high. The company has generated returns on investments over the last 12 months (13.38%).
with sales reaching $1.4B over the same period.The EPS is expected to grow by 0.96% this year, but quarterly earnings will post 6.93% year-over-year. Quarterly sales are estimated to shrink -12.34% in year-over-year returns.
Edwards Lifesciences Corp (EW) Top Institutional Holders
The shares outstanding are 588.60M, and float is at 576.41M with Short Float at 2.06%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 53.58 million shares valued at $4.95 billion. The investor’s holdings represent 8.9056% of the EW Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 50.98 million shares valued at $4.71 billion to account for 8.4733 of the shares outstanding. The other top investors are STATE STREET CORP which holds 26.01 million shares representing 4.3197% and valued at over $2.4 billion, while ALLIANCEBERNSTEIN L.P. holds 3.3812 of the shares totaling 20.34 million with a market value of $1.88 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by Zovighian Bernard J, the company’s CEO. SEC filings show that Zovighian Bernard J sold 6,164 shares of the company’s common stock on Mar 10 ’25 at a price of $69.51 per share for a total of $0.43 million. Following the sale, the insider now owns 59083.0 shares.
Edwards Lifesciences Corp disclosed in a document filed with the SEC on Mar 10 ’25 that Lippis Daniel J. (CVP, JAPAC) sold a total of 400 shares of the company’s common stock. The trade occurred on Mar 10 ’25 and was made at $69.48 per share for $27792.0. Following the transaction, the insider now directly holds 22588.0 shares of the EW stock.
Still, SEC filings show that on Mar 10 ’25, Zovighian Bernard J (Officer) Proposed Sale 6,164 shares at an average price of $69.51 for $0.43 million. The insider now directly holds shares of Edwards Lifesciences Corp (EW).
